Quantcast
Browsing all 1368 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

TRACT Therapeutics and Taiwan Bio Therapeutics Announce Poster Presentation...

  CHICAGO & TAIPEI, Taiwan TRACT Therapeutics and Taiwan Bio Therapeutics are pleased to announce a poster presentation at the 2024 annual meeting of the American Transplant Congress (ATC) taking...

View Article


Image may be NSFW.
Clik here to view.

Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement

  TOKYO & DUBLIN Ricoh Company, Ltd. today announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited (“ERS Genomics”) for access to the foundational CRISPR/Cas9...

View Article


Image may be NSFW.
Clik here to view.

Inocras Inc. Unveils Rebranding of Genome Insight

  SAN DIEGO Inocras, formerly known as Genome Insight, announced today its rebranding initiative to reflect its commitment to innovation and user-centric healthcare solutions. The AI-driven whole...

View Article

Image may be NSFW.
Clik here to view.

MilliporeSigma Invests More than € 300 Million in New Life Science Production...

  BURLINGTON, Mass. MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, invests more than €300 million into a new Bioprocessing Production Center in Daejeon,...

View Article

Image may be NSFW.
Clik here to view.

Charles River Announces Extension of Gene Therapy Manufacturing Alliance with...

  WILMINGTON, Mass. Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical education...

View Article


Image may be NSFW.
Clik here to view.

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific...

  BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with...

View Article

Image may be NSFW.
Clik here to view.

百奥赛图与ABL Bio达成合作,共同开发新型双抗ADC药物

  中国北京 (美国商业资讯)– 百奥赛图(北京)医药科技股份有限公司(“百奥赛图”,股票代码02315.HK),一家创新技术驱动抗体类新药研发的国际性生物技术公司今日宣布与ABL Bio Inc.(“ABL”,KOSDAQ:298380),一家处于临床阶段开发新型肿瘤和中枢神经系统疾病疗法的韩国生物技术公司达成合作,共同开发新型双特异性抗体偶联药物(双抗ADC)。...

View Article

Image may be NSFW.
Clik here to view.

バイオサイトジェン、新たな二重特異性抗体薬物複合体(ADC)の開発に向けて、ABL Bioとの提携を発表

  北京 (ビジネスワイヤ) — 新規抗体治療薬の発見と開発に注力する世界的なバイオテクノロジー企業であるバイオサイトジェン製薬(北京)株式会社(以下「バイオサイトジェン」、HKEX:02315)と、韓国の臨床段階バイオテクノロジー企業で、腫瘍学および中枢神経系疾患の治療法開発に特化したABL...

View Article


Image may be NSFW.
Clik here to view.

Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual...

  DUBLIN ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent...

View Article


Image may be NSFW.
Clik here to view.

SillaJen Submits CSR to the US FDA for REN026 Study in Patients with RCC

  SEOUL, South Korea SillaJen, Inc. (KOSDAQ: 215600) has submitted CSR to the US FDA on 06 Feb 2024 for REN026, a phase 1b/2a dose escalation and safety/efficacy evaluation study of Pexa-Vec in...

View Article

Image may be NSFW.
Clik here to view.

Propanc Biopharma’s CEO Shares Views on Revolutionizing Cancer Treatment: An...

  MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...

View Article

Image may be NSFW.
Clik here to view.

Modalis Announces Partnership with Ginkgo Bioworks

  TOKYO & WALTHAM, Mass. Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into an agreement with Ginkgo Bioworks (Ginkgo) to join the Ginkgo...

View Article

Image may be NSFW.
Clik here to view.

佐賀大学とBostonGeneがEGFR陽性肺癌患者におけるICIの治療効果予測因子を特定するための新規バイオマーカー探索を目的とした研究を発表

  WALTHAM, Mass. (ビジネスワイヤ) — 2024年4月16日、佐賀大学医学部附属病院はBostonGene(本社:米国マサチューセッツ州ウォルサム)との間で上皮成長因子受容体(EGFR)陽性肺癌患者における免疫チェックポイント阻害剤(ICI)の治療効果予測因子のバイオマーカー研究を推進することで合意しました。...

View Article


Image may be NSFW.
Clik here to view.

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers...

  WALTHAM, Mass. BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, and Saga University located in Saga, Japan and known for its commitment to educating and training...

View Article

Image may be NSFW.
Clik here to view.

Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease...

  SHANGHAI Codone Biotechnology, which develops transformative medicines based on Suppressor-tRNAs for patients with severe diseases caused by nonsense mutations (aka, Premature Termination Codons),...

View Article


Image may be NSFW.
Clik here to view.

Rubedo Life Sciences完成了由Khosla Ventures和Ahren Innovation Capital领投的4000万美元A轮融资

  加利福尼亚州, 桑尼维尔 (美国商业资讯)– Rubedo Life Sciences是一家生物制药公司,致力于开发针对驱动与年龄相关疾病的老化细胞的首创疗法,今日宣布完成了4000万美元的A轮融资。本轮融资由Khosla Ventures和Ahren Innovation Capital领投,Hevolution、R42、Modi Ventures、Cerigo...

View Article

Image may be NSFW.
Clik here to view.

ルベド・ライフ・サイエンシズ、コスラ・ベンチャーズとアーレン・イノベーション・キャピタル主導の4,000万ドルのシリーズA資金調達を完了

  カリフォルニア州サニーベール (ビジネスワイヤ) —...

View Article


Image may be NSFW.
Clik here to view.

Ochre Bio宣布与Boehringer Ingelheim合作,为晚期肝病患者开发新型再生疗法

  英国牛津 (美国商业资讯)– 慢性肝病药物开发领域的先驱Ochre Bio今天宣布与Boehringer Ingelheim建立合作伙伴关系,将专注于研究和开发治疗慢性肝病(CLD),例如晚期代谢性脂肪肝炎(MASH)肝硬化的第一线创新再生疗法。 根据这一合作伙伴关系,Ochre...

View Article

Image may be NSFW.
Clik here to view.

ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表

  CAMBRIDGE, Mass. (ビジネスワイヤ) — RNA医薬品の無限の可能性にチャレンジする企業、ReNAgade Therapeuticsは、米国遺伝子細胞治療学会(ASGCT)で発表予定の口頭およびポスタープレゼンテーションの内容を発表しました。このプレゼンテーションでは、同社の包括的なRNA技術プラットフォームを裏付ける前臨床データが焦点となります。第27回ASGCT年次総会は、...

View Article

Image may be NSFW.
Clik here to view.

ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲

  马萨诸塞州剑桥 (美国商业资讯)– 释放RNA药物无限潜力的公司ReNAgade Therapeutics今天宣布,将在2024年5月7-11日于马里兰州巴尔的摩市举行的美国基因与细胞治疗学会(ASGCT)第27届年会上进行口头报告和海报展示,重点介绍支持其全面RNA技术平台的临床前数据。 ReNAgade首席科学官Pete...

View Article
Browsing all 1368 articles
Browse latest View live